ARCHIVES

CHOP Evaluation Plan In Jan. 22 Issue

This article is from The Cancer Letter archive.

Vol. 08 No. 03 | January 15, 1982

Download PDF Visit The Full Archive

Related Articles

Chabner : Opportunity To Set Own Agenda Reason For Leaving

October 28, 1994

NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training

November 27, 1998

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

“Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million

December 6, 1974

Ivax Paclitaxel To Remain On Market In Deal With BMS.

February 1, 2002